Early experience with the FDA's Breakthrough Devices program

Nat Biotechnol. 2020 Aug;38(8):933-938. doi: 10.1038/s41587-020-0636-7.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Device Approval* / legislation & jurisprudence
  • Equipment and Supplies*
  • Humans
  • Medical Device Legislation*
  • Product Surveillance, Postmarketing
  • United States
  • United States Food and Drug Administration / legislation & jurisprudence*